BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 1979896)

  • 1. [Molecular genetic studies in the von Willebrand's syndrome].
    Mannhalter C; Parzer S; Kyrle PA
    Wien Klin Wochenschr; 1990 Sep; 102(17):491-6. PubMed ID: 1979896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic linkage of two intragenic restriction fragment length polymorphisms with von Willebrand's disease type IIA. Evidence for a defect in the von Willebrand factor gene.
    Verweij CL; Quadt R; Briët E; Dubbeldam K; van Ommen GB; Pannekoek H
    J Clin Invest; 1988 Apr; 81(4):1116-21. PubMed ID: 2895123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family studies in von Willebrand's disease by analysis of restriction fragment length polymorphisms and an intragenic variable number tandem repeat (VNTR) sequence.
    Standen GR; Bignell P; Bowen DJ; Peake IR; Bloom AL
    Br J Haematol; 1990 Oct; 76(2):242-9. PubMed ID: 1982729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A de novo mutation in exon 28 of the von Willebrand factor gene in a patient with type IIA von Willebrand's disease coincides with an MboI polymorphism in the von Willebrand factor pseudogene.
    Pérez-Casal M; Daly M; Peake I
    Hum Mol Genet; 1993 Dec; 2(12):2159-61. PubMed ID: 7906590
    [No Abstract]   [Full Text] [Related]  

  • 5. von Willebrand disease investigated by two novel RFLPs.
    Bernardi F; Guerra S; Patracchini P; Volinia S; Buzzoni D; Ballerini G; Casonato A; Marchetti G
    Br J Haematol; 1988 Feb; 68(2):243-8. PubMed ID: 2894837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inheritance of type I and type III von Willebrand's disease in Israel: linkage analysis, carrier detection and prenatal diagnosis using three intragenic restriction fragment length polymorphisms.
    Inbal A; Kornbrot N; Zivelin A; Shaklai M; Seligsohn U
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):167-77. PubMed ID: 1351407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular biology of von Willebrand's disease.
    Standen GR; Peake IR
    Q J Med; 1991 May; 79(289):381-9. PubMed ID: 1681564
    [No Abstract]   [Full Text] [Related]  

  • 8. Recessive inheritance of von Willebrand's disease type I.
    Eikenboom JC; Reitsma PH; Peerlinck KM; Briët E
    Lancet; 1993 Apr; 341(8851):982-6. PubMed ID: 8096943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An infrequent DNA polymorphism associated with severe von Willebrand's disease.
    Caekebeke-Peerlinck KM; Bakker E; Briet E
    Br J Haematol; 1990 May; 75(1):78-81. PubMed ID: 1973902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic and blood coagulation characterization of "Swedish" families with von Willebrand's disease types I and III: new aspects of heredity.
    Anvret M; Blombäck M; Lindstedt M; Söderlind E; Tapper-Persson M; Thelander AC
    Hum Genet; 1992 May; 89(2):147-54. PubMed ID: 1350262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms underlying acquired von Willebrand syndrome associated with an IgM paraprotein.
    Mayerhofer M; Haushofer A; Kyrle PA; Chott A; Müllner C; Quehenberger P; Worel N; Traby L; Eichinger S
    Eur J Clin Invest; 2009 Sep; 39(9):833-6. PubMed ID: 19572993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The spectrum of von Willebrand's disease.
    Meyer D
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):229-33. PubMed ID: 316575
    [No Abstract]   [Full Text] [Related]  

  • 13. Carrier detection in severe (type III) von Willebrand disease using two intragenic restriction fragment length polymorphisms.
    Bahnak BR; Lavergne JM; Verweij CL; Rothschild C; Pannekoek H; Larrieu MJ; Meyer D
    Thromb Haemost; 1988 Oct; 60(2):178-81. PubMed ID: 2905841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical application of three polymorphic microsatellites in intron 40 of the human von Willebrand factor gene.
    Casaña P; Martinez F; Aznar JA; Lorenzo JI; Jorquera JI
    Haemostasis; 1995; 25(6):264-71. PubMed ID: 8586316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
    McCarroll DR; Ruggeri ZM; Montgomery RR
    J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Von Willebrand's syndrome (author's transl)].
    Larrieu MJ; Meyer D; Ardaillou N
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):371-82. PubMed ID: 303357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New mutations in exon 28 of the von Willebrand factor gene detected in patients with different types of von Willebrand's disease.
    Casaña P; Martínez F; Haya S; Tavares A; Aznar JA
    Haematologica; 2001 Apr; 86(4):414-9. PubMed ID: 11325649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intermittent thrombocytopenia as a manifestation of Von Willebrand's disease].
    Gómez García EB; Brouwers GJ; Kappers-Klunne MC; Leebeek FW; van Vliet HH
    Ned Tijdschr Geneeskd; 2002 Jun; 146(25):1192-5. PubMed ID: 12109311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Von Willebrand's disease--gene, molecule, clinical findings, treatment].
    Brosstad F
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2894-8. PubMed ID: 8236189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.